Medicare's $2,000 Drug Cap Explained: What Eliquis Users Actually Pay Before and After Hitting It in 2026

Let's start with a real person's situation.

You're 68 years old. You take Eliquis 5mg twice daily (apixaban, for atrial fibrillation), atorvastatin 40mg (generic, for cholesterol), and metformin 1000mg twice daily (generic, for type 2 diabetes). You heard that Medicare now has a $2,000 out-of-pocket cap on drug costs, so you figured your Part D costs were finally under control — and you didn't bother comparing plans during Open Enrollment.

Here's what your 2026 actually looks like: you're going to pay somewhere between $2,000 and $2,816 for your covered drugs this year, depending on which Part D plan you chose. And if you're in a Medicare Advantage plan that isn't working for you, the Medicare Advantage Open Enrollment Period closes March 31 — that's the deadline the Medicare Rights Center flagged this week, and it's your last window to make a change until fall.

Let's do the math together.

What the $2,000 Cap Actually Means (Not the Brochure Version)

Starting in 2025, the Inflation Reduction Act set a hard $2,000 annual out-of-pocket cap on Medicare Part D covered drugs. This is the number CMS calls your True Out-of-Pocket cost, or TrOOP. Once your TrOOP reaches $2,000, you pay $0 for the rest of the year for covered drugs — no more copays, no more coinsurance.

That's genuinely good news. Before this change, beneficiaries on expensive brand drugs could see out-of-pocket costs of $3,500 or more annually when the old coverage gap — the "donut hole" — hit. The donut hole, as we knew it through 2024, is effectively gone.

But here's what the brochure doesn't tell you:

The $2,000 is a ceiling, not a flat fee. You still pay every dollar on the way up to it. And depending on your plan's cost-sharing structure, you could be paying $145/month or $261/month for Eliquis before you reach that cap — which changes your monthly budget, even if your annual cap stays the same.

And the premium is completely separate. A $42/month premium plan costs you $504/year on top of the $2,000 TrOOP. That's a $2,504 year, not a $2,000 year.

The 2026 Part D Structure, Plain English

Before we run numbers, here's how Part D is designed this year:

Phase	What It Means	2026 Standard
Deductible	You pay full drug cost first	$590
Initial Coverage	You pay 25% coinsurance; plan pays 75%	Until TrOOP = $2,000
Catastrophic	You pay $0 for covered drugs	After TrOOP hits $2,000

TrOOP (True Out-of-Pocket) is the running total of what YOU pay — deductible plus copays/coinsurance. When it hits $2,000, the catastrophic phase begins and the plan pays 100% for covered drugs.

One note: the 2025 IRA changes also introduced a monthly installment option. Instead of paying large copays at the pharmacy when costs are high early in the year, beneficiaries can spread their estimated annual OOP across 12 equal monthly payments. This is a cash flow tool, not a savings tool — your total annual cost doesn't change.

Worked Example: Three Plans, One Drug List

Your drug list:

Eliquis 5mg, 60 tablets/month (no generic available) — estimated retail: $580/month
Atorvastatin 40mg (generic) — Tier 1, $0 copay on most plans
Metformin 1000mg (generic) — Tier 1, $0 copay on most plans

Plan A: $0 Premium / Tier 4 Eliquis at 33% Coinsurance

Monthly premium: $0
Annual premium cost: $0
Deductible: $590 (Eliquis fills this in month 1)
Cost-sharing after deductible: 33% of $580 = $191/month for Eliquis
Months to reach $2,000 TrOOP: $590 deductible + ($191 × ~7.4 months) = $2,000 → hits cap in month 8–9
Catastrophic phase: September–December → $0 copay for 4 months
Annual drug OOP: $2,000
Total annual cost (drugs + premium): $2,000

Plan B: $42/Month Premium / Tier 3 Eliquis at 25% Coinsurance (Preferred Pharmacy)

Monthly premium: $42
Annual premium cost: $504
Deductible: $590
Cost-sharing after deductible: 25% of $580 = $145/month for Eliquis
Months to reach $2,000 TrOOP: $590 deductible + ($145 × ~9.7 months) = $2,000 → hits cap in month 10–11
Catastrophic phase: November–December → $0 copay for 2 months
Annual drug OOP: $2,000
Total annual cost (drugs + premium): $2,504

Plan C: $68/Month Premium / Tier 4 Eliquis at 25% Coinsurance (Non-Preferred Pharmacy)

Monthly premium: $68
Annual premium cost: $816
Total annual cost (drugs + premium): $2,816

	Plan A	Plan B	Plan C
Monthly premium	$0	$42	$68
Annual premium	$0	$504	$816
Eliquis tier	Tier 4 (33%)	Tier 3 (25%)	Tier 4 (25%)
Annual drug OOP	$2,000	$2,000	$2,000
Total annual cost	$2,000	$2,504	$2,816
Month catastrophic kicks in	August	October	October

This is the kind of side-by-side annual cost calculation that Pelandri runs for your specific drug list — so you see total cost, not just monthly premium.

The counterintuitive takeaway: For Eliquis users, the lower-premium plan often wins outright. You pay $2,000 in TrOOP either way — the premium is pure add-on cost. The "better" coinsurance rate in Plan B doesn't reduce your total spend; it just spreads your $2,000 OOP more evenly across the year. That matters for monthly cash flow, but not for your annual bottom line.

When the $2,000 Cap Doesn't Help You

Here's the flip side. Not every Medicare beneficiary benefits equally from the $2,000 TrOOP cap.

If you only take generics, you may never reach $2,000 TrOOP at all. A person on metformin, atorvastatin, lisinopril, and amlodipine — all Tier 1 generics at $0 copay on most plans — might pay $50–$150/year in total drug costs. The cap is irrelevant. For that person, the premium is nearly the entire annual cost. A $68/month plan costs $816/year for drugs that could otherwise be covered for $15/month on a $0-premium plan.

The KFF research on insurance affordability — which consistently finds that people aren't comparing the full cost picture when they choose coverage — applies directly here. People see a premium and anchor to it. They don't run the annual math, and they don't account for what happens when their drug list changes. This is as true for Medicare Part D as it is for ACA marketplace plans.

As we've covered in The Prescription Drug Coverage Trap: How Formulary Tiers Cost You Thousands, the tier your specific drug lands on can swing your annual cost by $2,000 or more — and that placement changes every year.

Three Types of Part D Beneficiaries and What the Cap Means for Each

Type 1: Generic-only user The $2,000 cap is mostly irrelevant. You'll likely pay less than $300/year in drug costs. Premium is the primary annual cost driver. Prioritize $0 or low-premium plans with Tier 1 coverage for your specific generics.

Type 2: One expensive brand drug (like Eliquis) You will hit the $2,000 TrOOP cap, probably between month 8 and 11 depending on your plan's cost-sharing rate. Premium is added directly on top of your $2,000 OOP. Lower premium wins. Verify formulary coverage and prior authorization requirements before enrolling.

Type 3: Multiple expensive brand drugs (e.g., Eliquis + Jardiance) You'll hit $2,000 TrOOP significantly faster — potentially by May or June. This means more months in catastrophic ($0 copay), which helps with monthly cash flow. Your annual total is still $2,000 + premium. Formulary coverage for both drugs becomes critical — if one drug is excluded from the formulary, you pay full retail and it may not even count toward TrOOP.

You can model which category you fall into at Pelandri — enter your drug list and get the full annual cost breakdown across plans in your ZIP code.

The March 31 Deadline You Might Be Forgetting

Most people think of Medicare Open Enrollment as an October–December window. But there's a second, less-publicized enrollment opportunity: the Medicare Advantage Open Enrollment Period (MA OEP), which runs January 1 through March 31 each year.

Per the Medicare Rights Center's guidance this week, if you are currently enrolled in a Medicare Advantage plan and it's not working — the formulary changed, your drug costs are higher than expected, or your preferred pharmacy is out of network — you can make one plan change before March 31, with coverage effective the first of the following month.

You cannot switch to a standalone Part D plan during MA OEP if you want to keep Original Medicare separately, but you can switch to a different Medicare Advantage plan, including one with better drug coverage. If you've been watching your Eliquis copays this year and something feels wrong, now is the time to check.

This is also the moment to review whether your income qualifies you for Extra Help (also called the Low-Income Subsidy). Extra Help dramatically reduces your TrOOP cap — beneficiaries with full Extra Help have a $0 deductible and pay no more than $12.15 for brand drugs and $4.50 for generics in 2026. If your income is at or below 150% of the federal poverty level, it's worth applying through SSA before assuming the standard $2,000 cap is your floor. For a broader look at how first-time Medicare enrollees often underestimate these variables, Medicare Plan Selection: Why Most 65-Year-Olds Choose Wrong walks through the most common errors.

What to Do Before March 31

Pull your current plan's Explanation of Benefits. It shows your year-to-date TrOOP. If you're on Eliquis and already past $500, you're on track to hit the $2,000 cap by summer — and that's fine. But if you also paid a $42/month premium, that's $504 you could have avoided.
Check your formulary online. Every Part D plan posts its formulary on its website and on Medicare Plan Finder (medicare.gov). Verify your drugs are still covered, what tier they're on, and whether prior authorization is required.
Run the full annual cost, not the monthly premium. Premium + deductible + cost-sharing to $2,000 cap = your real number. Plans that look cheap at $0/month sometimes have high Tier 4 coinsurance that doesn't change your TrOOP total but does affect your monthly budget.
Check Extra Help eligibility. If your income and assets are below SSA's thresholds, Extra Help can reduce your effective Part D OOP by $1,500 or more per year.

The math here isn't complicated once you build the right spreadsheet — but building that spreadsheet for 30+ plans across your ZIP code is where most people give up. Pelandri runs this analysis for your specific drug list, so you can walk into the MA OEP window — or next fall's Open Enrollment — with actual numbers, not guesses.

Your Eliquis costs what it costs. What varies is whether you're paying $2,000 this year or $2,816. That difference is entirely about which plan you chose.

Sources

Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds. — KFF Medicare
The Annual Deadline to Make Certain Medicare Advantage Changes Is Fast Approaching — Medicare Rights Center
Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles — KFF Medicare
In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut — KFF Medicare
What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now — KFF Medicare

Medicare's $2,000 Drug Cap Explained: What Eliquis Users Actually Pay Before and After Hitting It in 2026